Skip to content
Explore our 2023 annual report to learn about the ground-breaking innovations in cancer research and care happening here at Columbia.
Our dedicated access representatives can help you make an appointment today.
We work with our communities and patients to remove access barriers to cancer prevention, screening, treatment and survivorship services.
The Edward P. Evans Center for Myelodysplastic Syndromes (MDS) takes an all-encompassing approach to the study and treatment of MDS.
We're dedicated to developing the next generation of researchers and physicians through cross-disciplinary training and fellowship programs
New research from HICCC members shows that higher blood glucose levels ‘attract’ cancer cells to spread to the liver.
Research from Dr. Ciccia's lab reveals the dual mechanism of SMARCAL1, a DNA translocase, and its potential as a therapeutic target.
Spotlighting new research from the Momen-Heravi lab on immunotherapy response in head and neck cancer and other solid tumor types.
New research by the labs of Nicholas Arpaia, PhD, (pictured) and Tal Danino, PhD, marks a major step forward in efforts to enlist non-pathogenic bacteria to combat cancer.
Dr. Matthew Dallos and colleagues have opened the first clinical trial testing an anti-IL-8 compound as a potential therapy against COVID-19.